Substance use behavior in teens living with chronic pain
#35
Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
Clinicians treating adolescents with chronic pain need to understand that cannabis use in this population may represent self-medication for pain management rather than recreational use, which requires different assessment and counseling approaches. This distinction is critical because it informs whether interventions should focus on pain control optimization, substance use prevention, or both simultaneously. Recognizing self-medication patterns helps clinicians address the underlying pain condition while reducing the risk of problematic substance use trajectories during a developmentally vulnerable period.
This study examined substance use patterns in adolescents with chronic pain, with particular attention to cannabis use motivations and co-occurring substance use. Adolescents with chronic pain who reported cannabis use demonstrated distinct behavioral patterns compared to pain-free peers, including differential rates of alcohol and other drug use. The findings highlight that teenagers managing chronic pain face unique vulnerabilities to polysubstance use, with cannabis serving as one component of a broader substance use landscape. Understanding the motivations driving cannabis use in this population—whether for pain relief, coping, or social reasons—is critical for clinicians developing treatment plans that address both pain management and substance use risk. These results suggest that pain management protocols for adolescents should include comprehensive substance use screening and counseling that specifically addresses cannabis and alcohol co-use patterns. Clinicians caring for teens with chronic pain should routinely assess all substance use alongside pain severity to identify and intervene on polysubstance use early.
“This observational data gives us a useful clinical signal about pain-related motivation for cannabis use in adolescents, but we need to be careful about interpreting causation or prevalence from a single study without knowing the population characteristics or potential selection bias. What it does tell us is that we should be asking adolescent patients with chronic pain directly about cannabis use and their perceived reasons for it, rather than assuming the answer.”
💊 This study highlights an important clinical reality: adolescents with chronic pain may turn to cannabis as a self-management strategy, potentially reflecting inadequate conventional pain treatment, psychological distress, or both. Healthcare providers caring for teens with chronic conditions should recognize that substance use in this population often signals unmet needs rather than simple behavioral deviance, though this does not minimize the documented risks of cannabis use during adolescent development. Important confounders include the severity and type of pain condition, concurrent mental health disorders, family history of substance use, and access to multimodal pain management alternatives—all of which should inform clinical assessment and risk stratification. Given the neurodevelopmental vulnerabilities of the adolescent brain and evolving cannabis potency, clinicians should routinely screen for substance use in teens with chronic pain while simultaneously strengthening evidence-based pain management including psychological support, physical rehabilitation, and judicious pharmacotherapy. A practical approach involves addressing the underlying pain condition and
💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
Have thoughts on this? Share it:
📄 Printable 1-Page Physician Patient Guide
Download or print Dr. Benjamin Caplan’s official clinical reference guide to share with your healthcare team.

